[go: up one dir, main page]

GT199900180AA - Composicion farmacéutica para ser aplicada a las mucosas . - Google Patents

Composicion farmacéutica para ser aplicada a las mucosas .

Info

Publication number
GT199900180AA
GT199900180AA GT199900180AK GT199900180K GT199900180AA GT 199900180A A GT199900180A A GT 199900180AA GT 199900180A K GT199900180A K GT 199900180AK GT 199900180 K GT199900180 K GT 199900180K GT 199900180A A GT199900180A A GT 199900180AA
Authority
GT
Guatemala
Prior art keywords
mucoses
pharmaceutical composition
mucosa
composition
thanks
Prior art date
Application number
GT199900180AK
Other languages
English (en)
Inventor
Yoshihisa Nishibe
Wataru Kinoshita
Hiroyuki Kawabe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26450407&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT199900180A(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT199900180AA publication Critical patent/GT199900180AA/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/22—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of calcitonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Otolaryngology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCIÓN PROVEE UNA COMPOSICIÓN FARMACÉUTICA PARA SER APLICADA A LAS MUCOSAS, A SER UTILIZADA EN LA TERAPIA CON DROGAS Y QUE COMPRENDE UNA SUSTANCIA NO SOLUBLE EN AGUA Y/O POCO SOLUBLE EN AGUA, UN MEDICAMENTO, Y UN MEDIO ACUOSO, Y QUE TIENE UNA PRESIÓN OSMÓTICA DE MENOS 290 MOSM. ESTA COMPOSICIÓN ES SUPERIOR A LAS COMPOSICIONES FARMACÉUTICAS CONVENCIONALES PARA SER APLICADAS SOBRE LAS MUCOSAS, GRACIAS A SU EFICIENTE Y ELEVADA PERMEABILIDAD A LA SANGRE, EN LUGAR DE LA MUCOSAA. LA PRESENTE INVENCIÓN PROVEE ADEMÁS UNA COMPOSICIÓN FARMACÉUTICA PARA SER APLICADA A LA MUCOSA, QUE COMPRENDE UNA AGENTE HEMOSTÁTICO Y UN MEDICAMENTO. ESTA COMPOSICÍÓN ES SUPERIOR A LAS COMPOSICIONES FARMACÉUTICAS CONVENCIONALES PARA SER APLICADAS A LA MUCOSA, GRACIAS A SU PERMEABILIDAD Y RETENCIÓN EN LA MUCOSA.
GT199900180AK 1998-04-21 1999-10-19 Composicion farmacéutica para ser aplicada a las mucosas . GT199900180AA (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11088898 1998-04-21
JP11088798 1998-04-21

Publications (1)

Publication Number Publication Date
GT199900180AA true GT199900180AA (es) 2006-08-29

Family

ID=26450407

Family Applications (2)

Application Number Title Priority Date Filing Date
GT199900180AK GT199900180AA (es) 1998-04-21 1999-10-19 Composicion farmacéutica para ser aplicada a las mucosas .
GT199900180A GT199900180A (es) 1998-04-21 1999-10-19 Composicion farmaceutica para ser aplicada a las mucosas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
GT199900180A GT199900180A (es) 1998-04-21 1999-10-19 Composicion farmaceutica para ser aplicada a las mucosas.

Country Status (36)

Country Link
US (3) US6939559B1 (es)
EP (1) EP0998916B1 (es)
JP (2) JP5142420B2 (es)
KR (1) KR100686901B1 (es)
CN (1) CN1304052C (es)
AT (1) ATE336986T1 (es)
AU (1) AU757772B2 (es)
BG (1) BG64919B1 (es)
BR (1) BRPI9906372B8 (es)
CA (1) CA2294457C (es)
CY (1) CY1105771T1 (es)
CZ (1) CZ298466B6 (es)
DE (1) DE69932905T2 (es)
DK (1) DK0998916T3 (es)
EA (1) EA002967B1 (es)
EE (1) EE05072B1 (es)
ES (1) ES2272064T3 (es)
GE (1) GEP20022669B (es)
GT (2) GT199900180AA (es)
HR (1) HRP990402C1 (es)
HU (1) HU226712B1 (es)
ID (1) ID24818A (es)
IL (1) IL133614A (es)
IS (1) IS2453B (es)
NO (1) NO328270B1 (es)
NZ (1) NZ501950A (es)
PL (1) PL197875B1 (es)
PT (1) PT998916E (es)
RS (1) RS49764B (es)
SI (1) SI0998916T1 (es)
SK (1) SK286101B6 (es)
TR (1) TR199903193T1 (es)
TW (1) TWI243687B (es)
UA (1) UA77640C2 (es)
WO (1) WO1999053899A1 (es)
ZA (1) ZA997727B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261836B1 (en) * 1996-10-01 2001-07-17 Geron Corporation Telomerase
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
NZ538954A (en) * 2002-08-30 2007-04-27 Altana Pharma Ag The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis and allergic conjunctivitis
JPWO2004052399A1 (ja) * 2002-12-10 2006-04-06 昭和薬品化工株式会社 局所麻酔用組成物
EP1572217B1 (en) * 2002-12-12 2008-08-20 Nycomed GmbH Combination medicament of r,r-formoterol and ciclesonide
US20050025825A1 (en) 2003-07-31 2005-02-03 Xanodyne Pharmacal, Inc. Tranexamic acid formulations with reduced adverse effects
ES2452691T5 (es) * 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
JP4128521B2 (ja) * 2003-12-19 2008-07-30 信越化学工業株式会社 ゲル状シート及びその製造方法
US20050244495A1 (en) 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US7947739B2 (en) 2004-03-04 2011-05-24 Ferring B.V. Tranexamic acid formulations
US8022106B2 (en) 2004-03-04 2011-09-20 Ferring B.V. Tranexamic acid formulations
US20090215898A1 (en) 2004-03-04 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
WO2005102354A1 (en) * 2004-04-20 2005-11-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
EP1591106B1 (en) * 2004-04-28 2009-07-22 Shin-Etsu Chemical Co., Ltd. Film preparation and process for preparing the same
US20070231396A1 (en) * 2006-03-29 2007-10-04 Ray Charles D Medication spray formulation
WO2009114192A2 (en) * 2008-03-14 2009-09-17 Cephalon, Inc. Enhanced transmucosal composition and dosage form
ES2657686T3 (es) * 2009-06-24 2018-03-06 Lipoid Gmbh Composición para aplicaciones cosméticas, farmacéuticas o dietéticas
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide
CA2812299C (en) 2010-09-23 2020-08-04 Inflammagen, Llc Administration of serine protease inhibitors to the stomach
EP2661308B1 (de) * 2011-01-05 2019-05-08 Prenatal International GmbH Hypotone wässrige zusammensetzung mit verringertem chloridgehalt mit oder ohne phospholipide
ES2375784B1 (es) 2011-12-22 2013-01-24 Laboratorios Kin S.A. Gel de ácido tranexámico
CN112641771B (zh) 2014-03-25 2022-04-15 恒翼生物医药科技(上海)有限公司 用于治疗自身消化的组合物
CN104473864B (zh) * 2014-11-25 2017-02-22 陈长潭 一种卡络磺钠半固体制剂及其制备方法
PT3369429T (pt) 2015-10-30 2020-02-20 Teijin Pharma Ltd Composição farmacêutica para administração na mucosa nasal
US11666532B2 (en) 2018-01-19 2023-06-06 Hyloris Developments Sa Tranexamic acid oral solution
US20230364188A1 (en) * 2020-09-25 2023-11-16 Astellas Pharma Inc. Pharmaceutical composition for otic administration
JP2022130270A (ja) * 2021-02-25 2022-09-06 シンバイオシス株式会社 腸管吸収用補助剤及びその利用方法
EP4062919A1 (de) 2021-03-24 2022-09-28 Prenatal International GmbH Eine oder mehrere zusammensetzungen auf basis des menschlichen fruchtwassers zur anwendung in einem verfahren zur enteralen ernährung, zur enteralen ernährungsergänzung und/oder zur behandlung und/oder versorgung von kapillararmen schichten

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271143A (en) 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
CH657779A5 (de) 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
IL70489A0 (en) 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
JPS6034925A (ja) * 1983-08-04 1985-02-22 Mitsubishi Chem Ind Ltd ２−ヒドロキシイソフタルアルデヒド類の製造法
EP0501523B1 (en) 1983-11-14 1997-04-09 Columbia Laboratories, Inc. Bioadhesive compositions
JPS60123426A (ja) * 1983-12-07 1985-07-02 Eisai Co Ltd 経鼻投与用セクレチン製剤
JPS60224616A (ja) 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物
NZ222907A (en) 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
US5179079A (en) 1986-12-16 1993-01-12 Novo Nordisk A/S Nasal formulation and intranasal administration therewith
MY102411A (en) 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
JPS63303031A (ja) 1987-05-30 1988-12-09 Nippon Piston Ring Co Ltd コンプレッサ用ベ−ン
JPS63303931A (ja) * 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
EP0308181A1 (en) * 1987-09-14 1989-03-22 Novo Nordisk A/S Trans-mucosal delivery formulations and a method for preparation thereof
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5776493A (en) 1989-07-14 1998-07-07 Alza Corporation Oral osmotic device for delivery of nystatin with hydrogel driving member
DK0431719T3 (da) 1989-10-31 1995-02-27 Columbia Lab Inc Vaginalt vævsbefugtende præparat
US5147654A (en) 1990-07-23 1992-09-15 Alza Corporation Oral osmotic device for delivering nicotine
JPH078806B2 (ja) * 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
GB9102579D0 (en) * 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
GB9103824D0 (en) 1991-02-23 1991-04-10 Fisons Ag Formulation
DK0578780T3 (da) 1991-04-03 2003-08-18 Univ Vanderbilt Sænkning af thromboxanniveauer ved perkutan indgivelse af aspirin
US5200195A (en) 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
NZ245514A (en) * 1991-12-27 1994-12-22 Merck & Co Inc Controlled release drug delivery device comprising a core and a polymeric coating which is water impermeable but contains apertures to expose the core
CN1075081A (zh) * 1992-02-01 1993-08-11 解放军陆军第44医院 复方胶体麻醉剂的配制方法
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
JP3047948B2 (ja) 1992-12-07 2000-06-05 株式会社ツムラ ペプチド類経鼻投与用組成物
US5340572A (en) 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5409703A (en) 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
JP3781792B2 (ja) 1993-12-27 2006-05-31 千寿製薬株式会社 ジフルプレドナート含有点眼用懸濁液剤
JPH07188059A (ja) * 1993-12-28 1995-07-25 Rohto Pharmaceut Co Ltd 歯周病治療剤
RU2102979C1 (ru) 1994-07-18 1998-01-27 Панкрушева Татьяна Александровна Средство для лечения гнойно-воспалительных процессов кожи и слизистых оболочек различной этиологии
WO1997001337A1 (en) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
JP3098401B2 (ja) 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
JP2791317B2 (ja) 1995-12-26 1998-08-27 株式会社三和化学研究所 多層フィルム製剤
ATE247456T1 (de) 1996-02-27 2003-09-15 Teijin Ltd Puderförmige zusammensetzung zur nasalen anwendung
JPH09253220A (ja) 1996-03-26 1997-09-30 Kaajiopeeshingu Res Lab:Kk 生体内に植え込み可能なリード
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
RU2111829C1 (ru) 1996-10-09 1998-05-27 Буркин Сергей Павлович Способ непрерывного получения тонкой металлической полосы и машина для его осуществления
US5955097A (en) 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
TW503113B (en) 1997-01-16 2002-09-21 Senju Pharma Co Aqueous suspension for nasal administration
JP4009355B2 (ja) 1997-10-02 2007-11-14 村樫石灰工業株式会社 芝草地に発生するコケ・藻類の防除用組成物及び防除方法
RU11829U1 (ru) 1999-05-05 1999-11-16 Специальное конструкторское бюро транспортного машиностроения (ОАО Спецмаш) Рабочая площадка для буровых установок

Also Published As

Publication number Publication date
ES2272064T3 (es) 2007-04-16
IS2453B (is) 2008-11-15
EA002967B1 (ru) 2002-12-26
KR20010014067A (ko) 2001-02-26
CA2294457C (en) 2008-06-17
ATE336986T1 (de) 2006-09-15
DK0998916T3 (da) 2006-12-11
SI0998916T1 (sl) 2007-02-28
WO1999053899A1 (en) 1999-10-28
IS5312A (is) 1999-12-20
DE69932905D1 (de) 2006-10-05
NO996323D0 (no) 1999-12-20
BR9906372A (pt) 2000-07-11
UA77640C2 (uk) 2007-01-15
SK286101B6 (sk) 2008-03-05
IL133614A (en) 2004-12-15
CN1272784A (zh) 2000-11-08
TR199903193T1 (xx) 2000-11-21
NZ501950A (en) 2003-04-29
CZ460499A3 (cs) 2000-05-17
EP0998916A4 (en) 2002-06-19
CY1105771T1 (el) 2011-02-02
DE69932905T2 (de) 2007-04-05
EP0998916A1 (en) 2000-05-10
HUP0002512A2 (hu) 2000-12-28
BG64919B1 (bg) 2006-09-29
CA2294457A1 (en) 1999-10-28
NO996323L (no) 2000-02-18
US20030008019A1 (en) 2003-01-09
PL337534A1 (en) 2000-08-28
JP5142420B2 (ja) 2013-02-13
HRPK990402B1 (hr) 2001-08-31
EP0998916B1 (en) 2006-08-23
BRPI9906372B1 (pt) 2015-09-01
ZA997727B (en) 2000-10-12
IL133614A0 (en) 2001-04-30
TWI243687B (en) 2005-11-21
US7235247B2 (en) 2007-06-26
HRP990402A2 (en) 2000-04-30
PT998916E (pt) 2006-12-29
HUP0002512A3 (en) 2001-03-28
CZ298466B6 (cs) 2007-10-10
EA200000060A1 (ru) 2000-08-28
AU757772B2 (en) 2003-03-06
KR100686901B1 (ko) 2007-02-26
AU3534399A (en) 1999-11-08
BG104020A (en) 2000-05-31
RS49764B (sr) 2008-04-04
ID24818A (id) 2000-08-24
PL197875B1 (pl) 2008-05-30
US20050181054A1 (en) 2005-08-18
JP2004099624A (ja) 2004-04-02
HU226712B1 (en) 2009-07-28
GEP20022669B (en) 2002-04-25
US6939559B1 (en) 2005-09-06
EE05072B1 (et) 2008-10-15
EE9900589A (et) 2000-08-15
SK182399A3 (en) 2000-07-11
HRP990402C1 (en) 2008-09-30
BRPI9906372B8 (pt) 2021-05-25
NO328270B1 (no) 2010-01-18
CN1304052C (zh) 2007-03-14
YU54499A (sh) 2002-06-19
GT199900180A (es) 2001-12-18

Similar Documents

Publication Publication Date Title
GT199900180AA (es) Composicion farmacéutica para ser aplicada a las mucosas .
PT936905E (pt) Pelicula soluvel em agua ou camada soluvel em agua que possuem molhabilidade imediata para aplicacao oral
ES2109832T3 (es) Composicion dermatologica o farmaceutica, procedimiento de preparacion y utilizacion
ES2176730T3 (es) Preparacion de cinta percutanea que contiene fentanilo.
DE69027022D1 (de) Lipidhilfstoffe für verabreichung durch die nase und örtliche anwendung
CA2222676A1 (en) New pharmaceutical composition with anaesthetic effect
ES2157308T3 (es) Gel de un medio apolar, su utilizacion para la preparacion de fluidos de perforacion a base de agua.
ES2095964T3 (es) Una composicion de excipiente liquida que forma un gel.
AR022161A1 (es) Un tisu facial y un metodo para secuestrar irritantes en la secrecion nasal.
BR0014878A (pt) Composição farmacêutica contendo ciclosonida para aplicação à mucosa
BR9913135A (pt) Formulação oral
ES2092559T3 (es) Formulacion farmaceutica que contiene penciclovir.
SV1999000181A (es) Composicion farmaceutica para ser aplicada a las mucosas ref. er/cr-203.689
AR019245A1 (es) Composicion farmaceutica para ser aplicada a las mucosas
CO4600680A1 (es) Procedimientos para la prevencion de la degradacion de la proteina c
CR6122A (es) Composicion farmaceutica para ser aplicada a las mucosas
IT1291895B1 (it) Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
BR9910465A (pt) Uso de um agente que mantém ou melhora a barreira de permeabilidade da gengiva
AR018465A1 (es) COMPOSICIoN FARMACÉUTICA SoLIDA ORAL, USO DE LA COMPOSICIoN PARA LA FABRICACIoN DE UN MEDICAMENTO PARA LA PREVENCIoN, LA MODULACIoN O EL TRATAMIENTO DE DOLOR O INCOMODIDAD VISCERAL, PARA LA MODULACIoN DE LA SENSIBILIDAD O PERCEPCIoN VISCERAL, PARA MEJORAR LA PERCEPCIoN SENSORIAL DE LA DISTENCIoN REC
IT1304852B1 (it) Miscela di piante medicinali per la prevenzione e la cura delleemorroidi.